ArticleOncology letters2018

Activation of the TLR4/MyD88 signaling pathway contributes to the development of human hepatocellular carcinoma via upregulation of IL-23 and IL-17A.

Yuming Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.